Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
valaciclovir hydrochloride
Sandoz Pty Ltd
valaciclovir hydrochloride
Registered
VALACICLOVIR SZ 1 VALACICLOVIR SZ _Valaciclovir hydrochloride film-coated tablets _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Valaciclovir SZ. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT VALACICLOVIR SZ IS USED FOR This medicine is used to treat: • genital herpes infections (Herpes Simplex Virus, or HSV) • shingles (herpes zoster) and ophthalmic zoster (shingles affecting the eye region). This medicine is also used to prevent cytomegalovirus (CMV) infection and disease, following solid organ transplantation. CMV is another type of herpes virus. It can cause symptoms similar to glandular fever (high temperature, sore throat and swollen glands). It contains the active ingredient valaciclovir hydrochloride. Valaciclovir hydrochloride belongs to a group of medicines called antivirals. It works by stopping the multiplication of the viruses which cause these infections. FOR GENITAL HERPES INFECTIONS: Although Valaciclovir SZ does not cure the infection, it can reduce the length and severity of an outbreak of herpes, the duration of pain and shorten the time to healing. It also helps blisters to heal more quickly. If you start taking them as soon as you feel an outbreak starting, you may prevent the blisters from developing. Valaciclovir SZ tablets can be taken long term to prevent the HSV infection coming back. It can also reduce the risk of transmitting the virus that causes genital herpes in patients who are taking it continuously to prevent or reduce recurrent outbreaks. This medicine (or any other antiviral) does not cure genital herpes or completely eliminates the risk Read the complete document
190206-Valaciclovir SZ-pi Page 1 of 23 AUSTRALIAN PRODUCT INFORMATION VALACICLOVIR SZ ® (VALACICLOVIR HYDROCHLORIDE) FILM- COATED TABLETS 1 NAME OF THE MEDICINE Valaciclovir Hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Valaciclovir SZ tablets contain the active ingredient valaciclovir hydrochloride. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Valaciclovir SZ 500 mg capsule shaped film coated tablets - White to off-white capsule shaped film coated tablets with ‘500’ debossed on one side and plain on other side. Valaciclovir SZ 1000 mg capsule shaped film coated tablets * - White to off-white, capsule shaped film coated tablets with “1000” debossed on one side and plain on other side. * Not currently marketed in Australia 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS For the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. For the treatment of ophthalmic zoster. For the treatment of clinical episodes of genital herpes simplex infections. For the prevention of recurrent genital herpes. Reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. In addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see Section 4.4 Special warnings and precautions for use). Prophylaxis of cytomegalovirus (CMV) infection and disease following solid organ transplantation in patients at risk of CMV disease. 4.2 D OSE AND METHOD OF ADMINISTRATION DOSAGE _ADULTS _ _Herpes Zoster: _ 1000 mg of valaciclovir three times a day for seven days. _ _ _Genital Herpes: _ First clinical presentation, 500 mg of valaciclovir twice a day for 5 to 10 days. For recurrent episodes of genital herpes, 500 mg twice daily for 5 days. Dosing should begin as early as possible. For recurrent episodes of genital herpes, this should ideally be during the prodromal period or immediately following the appearance of the first signs or symptoms. 19020 Read the complete document